Clinical Research Directory
Browse clinical research sites, groups, and studies.
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
Sponsor: Nantes University Hospital
Summary
The aim of our study is to confirm the relevance of PET using \[68Ga\]Ga -PentixaFor ligand, in comparison with FDG, for initial staging and therapeutic evaluation of symptomatic multiple myeloma patients in first line treatment or in relapse. The prognostic value of positive CXCR4 expression will also be assessed and \[68Ga\]Ga -PentixaFor/FDG discordances explored.
Official title: Exploratory Study Evaluating the Relevance of [68Ga]Ga -PentixaFor for Initial Staging and Therapeutic Evaluation of Symptomatic Multiple Myeloma Patients in First Line Treatment or in Relapse
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2021-09-21
Completion Date
2030-05-21
Last Updated
2025-12-08
Healthy Volunteers
No
Conditions
Interventions
[68Ga]Ga-PentixaFor
Tomography by emission of positons (PET) with theradiopharmaceutic \[68Ga\]Ga-PentixaFor
Locations (5)
CHU Bordeaux
Bordeaux, France
CHU Lille
Lille, France
HCL
Lyon, France
Nantes UH
Nantes, France
APHP - Site Tenon
Paris, France